NHS England South West (the Commissioners) seeks to procure a Diabetic Eye Screening service for the South West.
The aim of the Diabetic Eye Screening programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment if necessary of sight threatening diabetic retinopathy, at the appropriate stage during the disease process. This will be achieved by delivering evidence-based, population-based screening programmes.
NHS England South West (the Commissioners) seeks to procure a Diabetic Eye Screening service for Lot 1 Cornwall and Isles of Scilly. NHS England South West will be the Contracting and Commissioning Authority for the Diabetic Eye Screening programme.
The aim of the Diabetic Eye Screening programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment if necessary of sight threatening diabetic retinopathy, at the appropriate stage during the disease process. This will be achieved by delivering evidence-based, population-based screening programmes that:
— identify the eligible population and ensure effective delivery with maximum coverage,
— are safe, effective, of a high quality, externally and independently monitored, and quality assured,
— lead to earlier detection, appropriate referral, effective treatment and improved outcomes,
— are delivered and supported by suitably trained, competent, and qualified, clinical and non-clinical staff who, where relevant, participate in recognised on-going Continuous Professional Development (CPD), and Quality Assurance (QA) schemes,
— have audit embedded in the service.
The specification is consistent with the national service specification which ensures there is a consistent and equitable approach to govern the provision and monitoring of NHS Diabetic Eye Screening Programmes (NDESP) across England. The purpose of the service specification for the NDESP is to outline the service and quality indicators expected by NHS England (the Commissioner) for their responsible population.
The provider will be required to deliver a service that incorporates the common pathway and meets the national service specification requirements. NDESP is currently in a development phase relating to the implementation of extended screening intervals and a single national IT solution. For 2018-2019, the national service specification reflects initial requirements to implement this development in 2019-2020.The provider will need to be adaptable to any new or changes to the national programme.
The current published national service specification for can be found here:
https://www.england.nhs.uk/wp-content/uploads/2017/04/service-spec-22.pdf
The contract is due to commence on 1.4.2019 and run for 4 years, with the option to extend for a further 1 year, at the Commissioners’ discretion.
The minimum expected total value of the contract, based on achieving minimum KPI uptake levels, is 3 427 411 GBP.
Interested parties who wish to take part in the procurement are invited to take part in an Invitation to Tender (ITT) process, based on the Open procedure and designed to identify the Most Economically Advantageous Tender and therefore determine the incoming provider. Instructions for taking part can be found below.
All ITT responses must be returned by 12:00 noon on 27.7.2018, at the latest.
A prior information / early engagement notice was published in relation to this procurement in April 2017, seeking expressions of interest. Please note that this previous notice was an information gathering exercise rather than a call for competition in its own right. Although those who responded to that notice will be advised that this contract notice has been published, there will be no process exemptions or preferential treatment afforded to any parties who expressed an interest at that stage.
This procurement is being carried out by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioners.
NHS England South West (the Commissioners) seeks to procure a Diabetic Eye Screening service for Lot 2 Devon. NHS England South West will be the contracting and Commissioning Authority for the Diabetic Eye Screening programme.
The aim of the Diabetic Eye Screening programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment if necessary of sight threatening diabetic retinopathy, at the appropriate stage during the disease process. This will be achieved by delivering evidence-based, population-based screening programmes that:
— identify the eligible population and ensure effective delivery with maximum coverage,
— are safe, effective, of a high quality, externally and independently monitored, and quality assured,
— lead to earlier detection, appropriate referral, effective treatment and improved outcomes,
— are delivered and supported by suitably trained, competent, and qualified, clinical and non-clinical staff who, where relevant, participate in recognised on-going Continuous Professional Development (CPD), and Quality Assurance (QA) schemes,
— have audit embedded in the service.
The specification is consistent with the national service specification which ensures there is a consistent and equitable approach to govern the provision and monitoring of NHS Diabetic Eye Screening Programmes (NDESP) across England. The purpose of the service specification for the NDESP is to outline the service and quality indicators expected by NHS England (the Commissioner) for their responsible population.
The provider will be required to deliver a service that incorporates the common pathway and meets the national service specification requirements. NDESP is currently in a development phase relating to the implementation of extended screening intervals and a single national IT solution. For 2018-2019, the national service specification reflects initial requirements to implement this development in 2019-2020.The provider will need to be adaptable to any new or changes to the national programme.
The current published national service specification for can be found here:
https://www.england.nhs.uk/wp-content/uploads/2017/04/service-spec-22.pdf
The contract is due to commence on 1.4.2019 and run for 4 years, with the option to extend for a further 1 year, at the Commissioners’ discretion.
The minimum expected total value of the contract, based on achieving minimum KPI uptake levels, is 7 401 558 GBP.
Interested parties who wish to take part in the procurement are invited to take part in an Invitation to Tender (ITT) process, based on the Open procedure and designed to identify the Most Economically Advantageous Tender and therefore determine the incoming provider. Instructions for taking part can be found below.
All ITT responses must be returned by 12:00 noon on 27.7.2018, at the latest.
A prior information / early engagement notice was published in relation to this procurement in April 2017, seeking expressions of interest. Please note that this previous notice was an information gathering exercise rather than a call for competition in its own right. Although those who responded to that notice will be advised that this Contract Notice has been published, there will be no process exemptions or preferential treatment afforded to any parties who expressed an interest at that stage.
This procurement is being carried out by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioners.
NHS England South West (the Commissioners) seeks to procure a Diabetic Eye Screening service for Lot 3 Somerset. NHS England South West will be the Contracting and Commissioning Authority for the Diabetic Eye Screening programme.
The aim of the Diabetic Eye Screening programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment if necessary of sight threatening diabetic retinopathy, at the appropriate stage during the disease process. This will be achieved by delivering evidence-based, population-based screening programmes that:
— identify the eligible population and ensure effective delivery with maximum coverage,
— are safe, effective, of a high quality, externally and independently monitored, and quality assured,
— lead to earlier detection, appropriate referral, effective treatment and improved outcomes,
— are delivered and supported by suitably trained, competent, and qualified, clinical and non-clinical staff who, where relevant, participate in recognised on-going Continuous Professional Development (CPD), and Quality Assurance (QA) schemes,
— have audit embedded in the service.
The specification is consistent with the national service specification which ensures there is a consistent and equitable approach to govern the provision and monitoring of NHS Diabetic Eye Screening Programmes (NDESP) across England. The purpose of the service specification for the NDESP is to outline the service and quality indicators expected by NHS England (the Commissioner) for their responsible population.
The provider will be required to deliver a service that incorporates the common pathway and meets the national service specification requirements. NDESP is currently in a development phase relating to the implementation of extended screening intervals and a single national IT solution. For 2018-2019, the national service specification reflects initial requirements to implement this development in 2019-2020.The provider will need to be adaptable to any new or changes to the national programme.
The current published national service specification for can be found here:
https://www.england.nhs.uk/wp-content/uploads/2017/04/service-spec-22.pdf
The contract is due to commence on 1.4.2019 and run for 4 years, with the option to extend for a further 1 year, at the Commissioners’ discretion.
The minimum expected total value of the contract, based on achieving minimum KPI uptake levels, is 2 924 952 GBP.
Interested parties who wish to take part in the procurement are invited to take part in an Invitation to Tender (ITT) process, based on the Open procedure and designed to identify the Most Economically Advantageous Tender and therefore determine the incoming provider. Instructions for taking part can be found below.
All ITT responses must be returned by 12:00 noon on 27.7.2018, at the latest.
A prior information / early engagement notice was published in relation to this procurement in April 2017, seeking expressions of interest. Please note that this previous notice was an information gathering exercise rather than a call for competition in its own right. Although those who responded to that notice will be advised that this Contract Notice has been published, there will be no process exemptions or preferential treatment afforded to any parties who expressed an interest at that stage.
This procurement is being carried out by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioners.
NHS England South West (the Commissioners) seeks to procure a Diabetic Eye Screening service for Lot 4 Bristol, North Somerset and South Gloucestershire. NHS England South West will be the Contracting and Commissioning Authority for the Diabetic Eye Screening programme.
The aim of the Diabetic Eye Screening programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment if necessary of sight threatening diabetic retinopathy, at the appropriate stage during the disease process. This will be achieved by delivering evidence-based, population-based screening programmes that:
— identify the eligible population and ensure effective delivery with maximum coverage,
— are safe, effective, of a high quality, externally and independently monitored, and quality assured,
— lead to earlier detection, appropriate referral, effective treatment and improved outcomes,
— are delivered and supported by suitably trained, competent, and qualified, clinical and non-clinical staff who, where relevant, participate in recognised on-going Continuous Professional Development (CPD), and Quality Assurance (QA) schemes,
— have audit embedded in the service.
The specification is consistent with the national service specification which ensures there is a consistent and equitable approach to govern the provision and monitoring of NHS Diabetic Eye Screening Programmes (NDESP) across England. The purpose of the service specification for the NDESP is to outline the service and quality indicators expected by NHS England (the Commissioner) for their responsible population.
The provider will be required to deliver a service that incorporates the common pathway and meets the national service specification requirements. NDESP is currently in a development phase relating to the implementation of extended screening intervals and a single national IT solution. For 2018-2019, the national service specification reflects initial requirements to implement this development in 2019-2020.The provider will need to be adaptable to any new or changes to the national programme.
The current published national service specification for can be found here:
https://www.england.nhs.uk/wp-content/uploads/2017/04/service-spec-22.pdf
The contract is due to commence on 1.4.2019 and run for 4 years, with the option to extend for a further 1 year, at the Commissioners’ discretion.
The minimum expected total value of the contract, based on achieving minimum KPI uptake levels, is 5 147 590 GBP.
Interested parties who wish to take part in the procurement are invited to take part in an Invitation to Tender (ITT) process, based on the Open procedure and designed to identify the Most Economically Advantageous Tender and therefore determine the incoming provider. Instructions for taking part can be found below.
All ITT responses must be returned by 12:00 noon on 27.7.2018, at the latest.
A prior information / early engagement notice was published in relation to this procurement in April 2017, seeking expressions of interest. Please note that this previous notice was an information gathering exercise rather than a call for competition in its own right. Although those who responded to that notice will be advised that this Contract Notice has been published, there will be no process exemptions or preferential treatment afforded to any parties who expressed an interest at that stage.
This procurement is being carried out by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioners
NHS England South West (the Commissioners) seeks to procure a Diabetic Eye Screening service for Lot 5 Gloucestershire. NHS England South West will be the Contracting and Commissioning Authority for the Diabetic Eye Screening programme.
The aim of the Diabetic Eye Screening programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment if necessary of sight threatening diabetic retinopathy, at the appropriate stage during the disease process. This will be achieved by delivering evidence-based, population-based screening programmes that:
— identify the eligible population and ensure effective delivery with maximum coverage,
— are safe, effective, of a high quality, externally and independently monitored, and quality assured,
— lead to earlier detection, appropriate referral, effective treatment and improved outcomes,
— are delivered and supported by suitably trained, competent, and qualified, clinical and non-clinical staff who, where relevant, participate in recognised on-going Continuous Professional Development (CPD), and Quality Assurance (QA) schemes,
— have audit embedded in the service.
The specification is consistent with the national service specification which ensures there is a consistent and equitable approach to govern the provision and monitoring of NHS Diabetic Eye Screening Programmes (NDESP) across England. The purpose of the service specification for the NDESP is to outline the service and quality indicators expected by NHS England (the Commissioner) for their responsible population.
The provider will be required to deliver a service that incorporates the common pathway and meets the national service specification requirements. NDESP is currently in a development phase relating to the implementation of extended screening intervals and a single national IT solution. For 2018-2019, the national service specification reflects initial requirements to implement this development in 2019-2020.The provider will need to be adaptable to any new or changes to the national programme.
The current published national service specification for can be found here:
https://www.england.nhs.uk/wp-content/uploads/2017/04/service-spec-22.pdf
The contract is due to commence on 1.4.2019 and run for 4 years, with the option to extend for a further 1 year, at the Commissioners’ discretion.
The minimum expected total value of the contract, based on achieving minimum KPI uptake levels, is 3 477 491 GBP.
Interested parties who wish to take part in the procurement are invited to take part in an Invitation to Tender (ITT) process, based on the Open procedure and designed to identify the Most Economically Advantageous Tender and therefore determine the incoming provider. Instructions for taking part can be found below.
All ITT responses must be returned by 12:00 noon on 27.7.2018, at the latest.
A prior information / early engagement notice was published in relation to this procurement in April 2017, seeking expressions of interest. Please note that this previous notice was an information gathering exercise rather than a call for competition in its own right. Although those who responded to that notice will be advised that this contract notice has been published, there will be no process exemptions or preferential treatment afforded to any parties who expressed an interest at that stage.
This procurement is being carried out by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioners.